SOURCE: INC Research

INC Research

October 19, 2010 08:06 ET

INC Research Sponsors FierceBiotech Executive Breakfast Roundtable to Discuss Priorities for Clinical Trial Success

Exclusive Meeting Features Prestigious Pharmaceutical Speaker Line-Up to Give Valuable Peer Perspectives on Global Drug Development

BOSTON, MA--(Marketwire - October 19, 2010) -   INC Research, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is proud to be a sponsor of FierceBiotech's Fierce Clinical Trials Insight Executive Breakfast on Wed., Oct. 27, from 8:00am-9:00am, held at the Westin Waterfront hotel in Boston.

Executives from AstraZeneca, Aveo, Cubist, and Sanofi-Aventis Pharmaceuticals will be providing their insights on success factors for clinical trials. The breakfast will be held in an intimate roundtable format where attendees will have the unique opportunity to collaborate with top executives regarding key issues in traditional trial design optimization, adaptive clinical trials, outsourcing of trials overseas, CRO consolidation and more. John Carroll, editor-in-chief of FierceBiotech, will be moderating the expert panel.

As clinical trials evolve, it is increasingly important that leaders gain industry direct insight to ensure success in drug development. The peer perspective offered at this event proves to be invaluable regarding clinical trial increasing pressures and new developments.

To register for FierceBiotech Executive Breakfast Meeting, click here.

Visit the INC Research website for more information on its clinical trials services, therapeutic expertise and Trusted Process.

About INC Research, Inc.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women's health trials. The company's The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com.

Contact Information